We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A surge in cell and gene therapy trials - an increase of 37% since 2017 - highlights the UK’s leading position as a developmental hub in this innovative industry, according to the Cell and Gene Therapy Catapult.